Cytori Therapeutics, Inc.

Robbins LLP Is Investigating the Officers and Directors of Cytori Therapeutics, Inc. (CYTX) on Behalf of Shareholders

Robbins LLP is investigating whether certain officers and directors of Cytori Therapeutics, Inc. (NASDAQ: CYTX) breached their fiduciary duties to shareholders. Cytori is a cell therapy company that develops cell therapies based on autologous adipose-deprived regenerative cells to treat cardiovascular disease and other medical conditions.

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, or you can complete the form below and we will contact you directly.

Send us a message for more information.